SAMSIC MEDICAL ANESTHESIE BLOC : revenue, balance sheet and financial ratios

SAMSIC MEDICAL ANESTHESIE BLOC is a French company founded 11 years ago, specialized in the sector Activités des agences de travail temporaire . Based in PARIS (75009), this company of category GE shows in 2024 a revenue of 22.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SAMSIC MEDICAL ANESTHESIE BLOC (SIREN 811158336)
Indicator 2024 2023 2022 2021 2020 2019 2017 2016
Revenue 22 915 113 € 16 407 272 € 13 375 326 € 7 604 670 € 6 650 094 € 5 492 311 € 3 577 006 € 3 576 979 €
Net income 532 347 € 1 097 701 € 1 698 910 € 593 346 € 250 274 € 413 871 € 124 755 € 68 640 €
EBITDA 1 041 945 € 1 467 073 € 2 261 862 € 789 319 € 327 621 € 581 843 € 172 089 € 93 424 €
Net margin 2.3% 6.7% 12.7% 7.8% 3.8% 7.5% 3.5% 1.9%

Revenue and income statement

In 2024, SAMSIC MEDICAL ANESTHESIE BLOC achieves revenue of 22.9 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +26.1%. Vs 2023, growth of +40% (16.4 M€ -> 22.9 M€). After deducting consumption (1 k€), gross margin stands at 22.9 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.0 M€, representing 4.5% of revenue. Warning negative scissor effect: despite revenue change (+40%), EBITDA varies by -29%, reducing margin by 4.4 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 532 k€, i.e. 2.3% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

22 915 113 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

22 913 976 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 041 945 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

657 222 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

532 347 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

4.5%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 3349%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 2%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 46.2 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 2.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3348.517%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

2.303%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

2.343%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

46.16

Solvency indicators evolution
SAMSIC MEDICAL ANESTHESIE BLOC

Sector positioning

Debt ratio
3348.52 2024
2022
2023
2024
Q1: 0.0
Med: 2.73
Q3: 26.78
Watch +54 pts over 3 years

In 2024, the debt ratio of SAMSIC MEDICAL ANESTHESIE... (3348.52) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
2.3% 2024
2022
2023
2024
Q1: 11.73%
Med: 25.56%
Q3: 44.76%
Average -40 pts over 3 years

In 2024, the financial autonomy of SAMSIC MEDICAL ANESTHESIE... (2.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
46.16 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.27 years
Watch +51 pts over 3 years

In 2024, the repayment capacity of SAMSIC MEDICAL ANESTHESIE... (46.16) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 484.79. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 41.1x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

484.793

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

41.069

Liquidity indicators evolution
SAMSIC MEDICAL ANESTHESIE BLOC

Sector positioning

Liquidity ratio
484.79 2024
2022
2023
2024
Q1: 111.16
Med: 138.5
Q3: 192.32
Excellent +20 pts over 3 years

In 2024, the liquidity ratio of SAMSIC MEDICAL ANESTHESIE... (484.79) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
41.07x 2024
2022
2023
2024
Q1: -0.69x
Med: 0.0x
Q3: 1.34x
Excellent +21 pts over 3 years

In 2024, the interest coverage of SAMSIC MEDICAL ANESTHESIE... (41.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 79 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 334 days. Excellent situation: suppliers finance 255 days of the operating cycle (retail model). Overall, WCR represents 432 days of revenue, i.e. 27.5 M€ to permanently finance. Over 2016-2024, WCR increased by +4090%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

27 499 511 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

79 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

334 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

432 j

WCR and payment terms evolution
SAMSIC MEDICAL ANESTHESIE BLOC

Positioning of SAMSIC MEDICAL ANESTHESIE BLOC in its sector

Comparison with sector Activités des agences de travail temporaire

Valuation estimate

Based on 135 transactions of similar company sales (all years), the value of SAMSIC MEDICAL ANESTHESIE BLOC is estimated at 1 782 137 € (range 1 020 307€ - 3 946 937€). With an EBITDA of 1 041 945€, the sector multiple of 2.0x is applied. The price/revenue ratio is 0.08x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
135 transactions
1020k€ 1782k€ 3946k€
1 782 137 € Range: 1 020 307€ - 3 946 937€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 041 945 € × 2.0x
Estimation 2 112 816 €
1 012 682€ - 4 977 297€
Revenue Multiple 30%
22 915 113 € × 0.08x
Estimation 1 762 918 €
1 383 534€ - 3 151 623€
Net Income Multiple 20%
532 347 € × 1.8x
Estimation 984 269 €
494 531€ - 2 564 010€
How is this estimate calculated?

This estimate is based on the analysis of 135 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des agences de travail temporaire )

Compare SAMSIC MEDICAL ANESTHESIE BLOC with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des agences de travail temporaire

Frequently asked questions about SAMSIC MEDICAL ANESTHESIE BLOC

What is the revenue of SAMSIC MEDICAL ANESTHESIE BLOC ?

The revenue of SAMSIC MEDICAL ANESTHESIE BLOC in 2024 is 22.9 M€.

Is SAMSIC MEDICAL ANESTHESIE BLOC profitable?

Yes, SAMSIC MEDICAL ANESTHESIE BLOC generated a net profit of 532 k€ in 2024.

Where is the headquarters of SAMSIC MEDICAL ANESTHESIE BLOC ?

The headquarters of SAMSIC MEDICAL ANESTHESIE BLOC is located in PARIS (75009), in the department Paris.

Where to find the tax return of SAMSIC MEDICAL ANESTHESIE BLOC ?

The tax return of SAMSIC MEDICAL ANESTHESIE BLOC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SAMSIC MEDICAL ANESTHESIE BLOC operate?

SAMSIC MEDICAL ANESTHESIE BLOC operates in the sector Activités des agences de travail temporaire (NAF code 78.20Z). See the 'Sector positioning' section above to compare the company with its competitors.